Related Experiment Video
Updated: Dec 22, 2025

07:31
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.4K
Insights
Scientific data and advice provided to the UK government regarding the coronavirus pandemic will not be released until the health crisis concludes. This delay impacts public access to crucial information.
Area of Science:
- Public Health
- Government Policy
- Epidemiology
Background:
- The coronavirus pandemic has necessitated significant scientific input for governmental decision-making.
- Transparency in scientific advice is crucial for public trust and understanding.
Purpose of the Study:
- To report on the delayed publication of key scientific data and advice given to the UK government.
- To highlight the timeline for the release of this information.
Main Methods:
- Reporting based on information from David Adam.
- Analysis of government communication regarding data release.
Main Results:
- Key scientific data and advice related to the coronavirus pandemic will be withheld from publication until the pandemic concludes.
- The decision impacts the accessibility of information for the public and researchers.
Conclusions:
- The current policy delays the dissemination of vital scientific information concerning a major public health event.
- Further information on the specific data and advice withheld is not provided in the report.
Abstract:
Key scientific data and advice to the UK government won't be published until the coronavirus pandemic ends, reports David Adam.
Related Concept Videos
Obedience
35.1K
According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation,...
35.1K
Ethical Dilemmas II
2.1K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
2.1K
Ethical Dilemmas I
1.7K
Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
1.7K
Drug Regulation
2.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.6K
Drug Control Governance: Regulatory Bodies and Their Impact
413
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
413
Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K

